The Indianapolis-based drugmaker earned $1.2 billion in the quarter, compared with $915 million in the same period a year ago. Profit per share beat Wall Street forecasts by a penny.
Eli Lilly and Co. probably will get approval for its newly acquired imaging agent used to diagnose Alzheimer’s disease, but so far analysts are unimpressed.
Alecia DeCoudreaux, the top attorney for Eli Lilly and Co.’s U.S. unit, will leave to become president of Mills College in Oakland, Calif. DeCoudreaux, 55, has worked at Indianapolis-based Lilly for 30 years after earning her law degree from Indiana University in Bloomington. As general counsel for its U.S. business, DeCoudreaux guided Lilly through all U.S. regulations, including its applications with the Food and Drug Administration to launch new drugs.
Carmel-based Zotec Partners has hired Bradley Myers as director of marketing. Prior to joining Zotec, Myers was the marketing specialist for Medical Management Professionals Inc. Myers has a marketing degree from George Mason University.
John H. Johnson, president of Indianapolis-based Eli Lilly and Co.’s oncology unit, will resign on Friday to become CEO of East Brunswick, N.J.-based biotechnology company Savient Pharmaceuticals Inc. Johnson had been CEO of New York-based ImClone Systems Inc. when Lilly acquired it in 2008.
Supreme Court justices on Monday left intact a ruling throwing out a lawsuit pressed by the Nashville, Tenn., university against Eli Lilly’s Icos subsidiary.
The local drugmaker told the International Trade Commission on Thursday that the generic version of Gemzar violates its patent on the process for making the active ingredient.
The city’s Economic Development Committee, which was set to vote on the downtown project’s $98 million bond financing package on Tuesday, chose to wait until February after making a few changes.
Eli Lilly and Co.’s Amyvid isn’t ready to be approved to detect Alzheimer’s-related deposits in the brain, according to FDA advisors. The medicine could still be approved if Lilly establishes a training program and a way to ensure that the results of brain scans are read consistently, they said.
A federal panel of medical experts said Thursday a first-of-a-kind imaging chemical designed to help screen for Alzheimer's disease could be useful pending additional study and training for physicians.
The state’s principal fund investing in high-tech companies has reached a milestone—for the first time recouping all the money it granted an emerging company, and then some.
“Twelve years after I popped out, I learned to sell. During the next three, I began to write. Fifty years later, I discovered how to kill.” Thus begins the journal of investment adviser Jack Chap, protagonist in John Guy’s novel “Middle Man, a Broker’s Tale.”
A former China-based executive of Allison Transmission has agreed to drop a lawsuit that claimed the company won business by bribing foreign officials. But it's likely that the firm still must deal with scrutiny from the Department of Justice, according to one legal expert.
Alecia DeCoudreaux, the top attorney for Eli Lilly and Co.’s U.S. unit and an active community volunteer, will leave to become president of Mills College in California on July 1.
